GLP-3 Retatrutide
US$ 21.61
when will tirzepatide be approved FDA Grants a New Indication for Obesity Management Tirzepatide approved for weight loss
Description
Is appetite suppression enough for a long-term fat loss
Participants on 5mg tirzepatide lost an average of 16% of body weight
Pre-filled pens or properly reconstituted vials allow exact measurement of the intended dose
They may spend months wondering why their results lag behind expectations
According to the platform's FAQ, some of the more common side effects include nausea, vomiting, and diarrhea
"That is my biggest fear."
